Arcus Biosciences, Inc. (RCUS) Insider Trading

Name: Arcus Biosciences, Inc. (RCUS) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Aug 24, 2026): Alexander Azoy (Chief Accounting Officer): Exercise/Conversion of 2,827 shares, $43.6K.

Get alerted when insiders trade RCUS

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta